Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

BACKGROUND: The effect of first‐line chemotherapy on overall survival (OS) may be significantly influenced by subsequent therapy for patients with extensive disease small cell lung cancer (ED‐SCLC). Therefore, we evaluated the relationship between progression‐free survival (PFS), post‐progression su...

Descripción completa

Detalles Bibliográficos
Autores principales: Masubuchi, Ken, Imai, Hisao, Wasamoto, Satoshi, Tsuda, Takeshi, Minemura, Hiroyuki, Nagai, Yoshiaki, Yamada, Yutaka, Kishikawa, Takayuki, Umeda, Yukihiro, Shiono, Ayako, Takechi, Hiroki, Shiihara, Jun, Kaira, Kyoichi, Kanazawa, Kenya, Taniguchi, Hirokazu, Kaburagi, Takayuki, Kagamu, Hiroshi, Minato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527159/
https://www.ncbi.nlm.nih.gov/pubmed/36062426
http://dx.doi.org/10.1111/1759-7714.14621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527159/
https://www.ncbi.nlm.nih.gov/pubmed/36062426
http://dx.doi.org/10.1111/1759-7714.14621

Ejemplares similares